Companies / Xilio Therapeutics, Inc. / Activity
Activity — Xilio Therapeutics, Inc.
2 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Shannon James Samuel Director | Buy | Common Stock | $44.0K | +5K +100.00% | 10,000 0.17% of shares | low |
| Feb 13, 2026 | Gilead Sciences, Inc. 10% owner | Buy | Prefunded Warrants (right to buy) | — | +3.7M +10.20% | 40,384,266 698.39% of shares | low |